Preclinical experiments advise that retatrutide could affect being overweight-affiliated most cancers development. In the analyze led by Marathe et al., retatrutide-induced weight loss reduced tumor engraftment, delayed tumor onset, and substantially attenuated tumor development in pancreatic and lu